Akèy › Kasinòm epitelyal ovè › Tennessee › Nashville
Etid klinik pou Kasinòm epitelyal ovè nan Nashville, TN
3 etid pou Kasinòm epitelyal ovè ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Ap rekriteFaz 3
- Sarah Cannon Research Institute (Oncology Associates of Oregon PC), Nashville
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Ap rekriteFaz 1
- Context Investigational Site, Nashville
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Ap rekriteFaz 1
- Vanderbilt University Medical Center, Nashville
Etid Kasinòm epitelyal ovè nan lòt vil
- Boston, MA8 etid
- Durham, NC8 etid
- New York City, NY7 etid
- San Diego, CA7 etid
- Chicago, IL7 etid
- Baltimore, MD6 etid
- Cleveland, OH6 etid
- Philadelphia, PA6 etid
- Houston, TX6 etid
- Portland, OR5 etid
- Minneapolis, MN5 etid
- Salt Lake City, UT5 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.